Unknown

Dataset Information

0

GPR110 promotes progression and metastasis of triple-negative breast cancer.


ABSTRACT: Breast cancer is the most common type of cancer in women, and approximately 70% of all breast cancer patients use endocrine therapy, such as estrogen receptor modulators and aromatase inhibitors. In particular, triple-negative breast cancer (TNBC) remains a major threat due to the lack of targeted treatment options and poor clinical outcomes. Here, we found that GPR110 was highly expressed in TNBC and GPR110 plays a key role in TNBC progression by engaging the RAS signaling pathway (via Gαs activation). High expression of GPR110 promoted EMT and CSC phenotypes in breast cancer. Consequently, our study highlights the critical role of GPR110 as a therapeutic target and inhibition of GPR110 could provide a therapeutic strategy for the treatment of TNBC patients.

SUBMITTER: Nam HJ 

PROVIDER: S-EPMC9132940 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

GPR110 promotes progression and metastasis of triple-negative breast cancer.

Nam Hye-Jung HJ   Kim Yeon-Ju YJ   Kang Jae-Hyeok JH   Lee Su-Jae SJ  

Cell death discovery 20220526 1


Breast cancer is the most common type of cancer in women, and approximately 70% of all breast cancer patients use endocrine therapy, such as estrogen receptor modulators and aromatase inhibitors. In particular, triple-negative breast cancer (TNBC) remains a major threat due to the lack of targeted treatment options and poor clinical outcomes. Here, we found that GPR110 was highly expressed in TNBC and GPR110 plays a key role in TNBC progression by engaging the RAS signaling pathway (via Gαs acti  ...[more]

Similar Datasets

| S-EPMC9027050 | biostudies-literature
| S-EPMC8196523 | biostudies-literature
| S-EPMC5832424 | biostudies-literature
| S-EPMC8131696 | biostudies-literature
| S-EPMC5008402 | biostudies-literature
| S-EPMC4302663 | biostudies-literature
| S-EPMC7244539 | biostudies-literature
| S-EPMC7260014 | biostudies-literature
| S-EPMC11555945 | biostudies-literature
| S-EPMC4131178 | biostudies-literature